Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies

Malignant mesothelioma is a rare form of cancer in which the cancer cells
are found in the sac lining the chest (pleura) or abdomen (peritoneum).
This lethal disease is associated with asbestos and has vast economic
and legal implications. As the disease takes approximately twenty years
to manifest itself in humans, a wave of diagnoses are expected in the
near future. In the United States alone, an estimated 3,500 – 4,000
patients are diagnosed with mesothelioma annually, and it is estimated that over the next 35 years, more than 250,000 people in Western Europe will be diagnosed with the disease. Malignant Mesothelioma,
edited by internationally recognized experts in the field, is a
comprehensive text that relates science, pathology, clinical aspects and
therapy for mesothelioma under one cover. The book integrates the
newest research and advances in its discussions of the disease, covering
such topics as carcinogenesis, epidemiology, benchwork, endoscopy,
multimodality approaches and treatment. It includes discussions on novel
approaches to mesothelioma, such as gene therapy, vaccination
strategies and immunotherapy, as well as discussions on the legal and
economic aspects of the disease. Over 200 illustrations round out the text. An invaluable reference for the medical oncologist, thoracic surgeon, radiation oncologist, pulmonologist, and benchworker interested in the disease..

GET IT HERE





Related Subjects
Platinum-Based Drugs in Cancer Therapy
Gastric Cancer (Contemporary Issues in Cancer Imaging)
 Handbook of Evidence-Based Radiation Oncology - June 2010 Edition
Mesothelioma
Endosurgery for Cancer (Vademecum)
Surgical Oncology (Vademecum)
The M.D. Anderson Surgical Oncology Handbook (Feig, M.D. Anderson Surgical Oncology Handbook)
MKSAP 15 HEMATOLOGY AND ONCOLOGY STUDY MATERIAL
Medstudy 2011: Video Board Review of Internal Medicine
Principles & Practice of Oncology DeVita, Hellman, and Rosenberg's Cancer